We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NAVB market cap is 7.78M. The company's latest EPS is USD -0.1724 and P/E is -0.46.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7k | 1,000 | 0 | 0 | 0 |
| Operating Income | -4.95M | -3.2M | -2.42M | -2.43M | -2.13M |
| Net Income | -7.75M | -3.48M | -1.48M | 5.83M | -2.26M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.17M | 658k | 915k | 532k | 66k |
| Operating Income | -10.85M | -10.96M | -10.71M | -12.06M | -14.05M |
| Net Income | -16.11M | -10.95M | -11.39M | -11.73M | -17.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.26M | 4.37M | 2.37M | 8.22M | 5.7M |
| Total Liabilities | 10.93M | 12.52M | 11.92M | 9.01M | 8.68M |
| Total Equity | -4.67M | -8.14M | -9.55M | -787k | -2.98M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.02M | 4.15M | 7.76M | 6.65M | 4.37M |
| Total Liabilities | 4.61M | 5.03M | 5.71M | 6.02M | 12.52M |
| Total Equity | 2.41M | -881k | 2.05M | 625k | -8.14M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.55M | -8.99M | -1.72M | 2.97M | -7.28M |
| Investing | -318k | -390k | -39k | -104k | 8.05M |
| Financing | 7.24M | 7.14M | -201k | 1.28M | 1.1M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.28M | -9.36M | -8.17M | -10.22M | -8.99M |
| Investing | 954k | 770k | -413k | -329k | -390k |
| Financing | -4.55M | 6.16M | 10.21M | 12.11M | 7.14M |
| Market Cap | 7.78M |
| Price to Earnings Ratio | -0.46 |
| Price to Sales Ratio | 114.29 |
| Price to Cash Ratio | 4 |
| Price to Book Ratio | -0.98 |
| Dividend Yield | - |
| Shares Outstanding | 99.83M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -62.00% |
| 52 Week High | 0.2099 |
| 52 Week Low | 0.0626 |
| Spread (Intraday) | 0.04 (44.76%) |
| Company Name | Navidea Biopharmaceuticals Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.navidea.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
